Gemphire Therapeutics Executives
Gemphire Therapeutics employs about 7 people. The company is managed by 11 executives with a total tenure of roughly 88 years, averaging almost 8.0 years of service per executive, having 0.64 employees per reported executive. Discussion of Gemphire Therapeutics' management performance can provide insight into the enterprise performance.
| Mina Sooch CEO President CEO |
| Steven Gullans CEO Interim President Interim CEO, Director |
Gemphire |
Gemphire Therapeutics Workforce Comparison
Gemphire Therapeutics is one of the top stocks in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 38,438. Gemphire Therapeutics adds roughly 7.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Gemphire Therapeutics Notable Stakeholders
A Gemphire Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Gemphire Therapeutics often face trade-offs trying to please all of them. Gemphire Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Gemphire Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Charles Bisgaier | Co-Founder, Chief Scientific Officer | Profile | |
| David Lowenschuss | Co-Founder, Chief Legal Officer | Profile | |
| Mina Sooch | President CEO | Profile | |
| Steven Gullans | Interim President Interim CEO, Director | Profile | |
| Jeffrey Mathiesen | CFO | Profile | |
| Kenneth Kousky | Independent Director | Profile | |
| Andrew Sassine | Independent Director | Profile | |
| Pedro Lichtinger | Independent Director | Profile | |
| Kent Hawryluk | Independent Director | Profile | |
| Seth Reno | Chief Commercial Officer | Profile | |
| Lee Golden | Chief Medical Officer | Profile |
Gemphire Therapeutics Workforce Analysis
Traditionally, organizations such as Gemphire Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Gemphire Therapeutics within its industry.Gemphire Therapeutics Manpower Efficiency
Return on Gemphire Therapeutics Manpower
| Net Loss Per Employee | 2M | |
| Net Loss Per Executive | 1.3M | |
| Working Capital Per Employee | 1.2M | |
| Working Capital Per Executive | 734.5K |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Gemphire Stock
If you are still planning to invest in Gemphire Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gemphire Therapeutics' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |